Selegiline in Dogs
Generic: Selegiline
Selegiline is a selective, irreversible monoamine oxidase-B (MAO-B) inhibitor primarily used in veterinary medicine to manage canine cognitive dysfunction and certain pituitary-dependent endocrine disorders.
This medication is intended for dogs.
Overview
Selegiline, often known by its trade name Anipryl, is a potent pharmaceutical agent that functions as a selective inhibitor of the enzyme monoamine oxidase-B (MAO-B). While initially developed for human use in managing Parkinson's disease, it has become a cornerstone treatment in veterinary neurology and endocrinology. It is most commonly prescribed to dogs suffering from cognitive dysfunction syndrome (CDS), a condition analogous to dementia in humans, where the drug helps mitigate symptoms like confusion, disorientation, and altered sleep-wake cycles. Unlike Trilostane, which is used to manage hyperadrenocorticism by inhibiting cortisol synthesis, selegiline works by modulating neurotransmitter levels in the brain to improve executive function and quality of life for aging pets.
In addition to its cognitive applications, selegiline is employed in the medical management of pituitary-dependent hyperadrenocorticism (PDH), also known as Cushing's disease. While clinicians might consider Mitotane for more aggressive control of adrenal function, selegiline serves as an alternative for dogs with milder forms of PDH. Its mechanism in the endocrine system involves enhancing dopamine activity within the hypothalamus, which helps suppress excessive secretion of adrenocorticotropic hormone (ACTH). Unlike managing glucose levels with Insulin (Caninsulin/Vetsulin), which requires strict monitoring of blood sugar, selegiline therapy for Cushing's generally focuses on reducing systemic symptoms related to endocrine dysregulation.
Clinicians often evaluate the use of selegiline alongside other hormonal therapies, such as the administration of Levothyroxine for hypothyroidism, to ensure no synergistic adverse effects occur. It is imperative that pet owners recognize that selegiline is not a curative treatment for canine cognitive decline, but rather a long-term management strategy that requires patient adherence. Because the medication influences dopaminergic pathways, it is distinct from treatments like Leuprolide, which targets reproductive hormone pathways. Through regular follow-up consultations, veterinarians monitor the efficacy of the drug, making adjustments to dosage as the neurodegenerative progression continues, thereby extending the comfortable lifespan of the canine patient.
What It Treats
- Canine Cognitive Dysfunction (CCD): Helps manage symptoms like disorientation, house-soiling, and sleep pattern disturbances.
- Pituitary-Dependent Hyperadrenocorticism (PDH): Used to treat the clinical signs of Cushing's disease in dogs through dopaminergic modulation of the pituitary gland.
How It Works
Selegiline works by irreversibly inhibiting monoamine oxidase-B, an enzyme responsible for breaking down dopamine, phenylethylamine, and to a lesser extent, norepinephrine and serotonin in the central nervous system. By inhibiting this breakdown, selegiline increases the availability of these catecholamines in the synaptic cleft, which enhances dopamine-mediated neurotransmission and promotes healthier brain function. In the context of the hypothalamic-pituitary-adrenal axis, the increased dopaminergic tone resulting from selegiline inhibition helps to normalize the signaling processes that control ACTH release. This systemic improvement in dopaminergic activity can help alleviate the signs of excessive cortisol production and cognitive decline, providing a neuroprotective effect that supports cognitive resilience in aging dogs.
Dosage
The dosage for selegiline is strictly determined by a veterinarian based on the dog's body weight and the specific condition being treated. For cognitive dysfunction, a common starting dose is 0.5 mg/kg administered once daily, usually in the morning. For Cushing's disease, the dosage may be higher and adjusted based on clinical response. Always adhere strictly to the prescription labels; do not increase or decrease the dosage without veterinary approval.
Administration
Selegiline is typically administered orally in tablet form once daily, preferably in the morning to avoid interference with the dog's sleep cycle. It can be given with or without food, though giving it with a small meal may reduce the risk of gastrointestinal upset in sensitive dogs. Ensure the entire tablet is consumed and follow up with fresh water to encourage swallowing.
Storage
Selegiline should be stored in a tightly closed container at room temperature, generally between 68°F and 77°F (20°C to 25°C). Keep the medication away from light, moisture, and extreme heat. It must be kept strictly out of the reach of children and other pets, as accidental ingestion can lead to significant toxicity.
Contraindications
Selegiline is contraindicated in dogs with known hypersensitivity to the drug. It should not be used in animals receiving other monoamine oxidase inhibitors (MAOIs), such as amitraz (often found in tick collars) or certain antidepressants, as this can lead to severe, life-threatening serotonin syndrome or hypertensive crises. Additionally, use should be avoided in dogs with pre-existing severe cardiovascular disease or pheochromocytoma, as dopamine modulation can adversely affect heart rate and blood pressure. Care must be exercised when using selegiline in pregnant or lactating bitches, as safety profiles have not been fully established. If a dog is undergoing surgery, veterinarians generally advise a withdrawal period for selegiline to avoid potential complications with anesthetic agents, particularly those that might interact with catecholamine pathways.
Interactions
Selegiline has significant interactions with other drugs that affect central nervous system neurotransmitters. Specifically, it should not be administered within 14 days of using tricyclic antidepressants (like clomipramine) or selective serotonin reuptake inhibitors (SSRIs), as the combination can lead to serotonin toxicity. Furthermore, drugs like ephedrine, phenylpropanolamine, and certain opioids (e.g., meperidine) are contraindicated due to the risk of severe cardiovascular or neurological adverse events. Always inform your veterinarian of all medications, supplements, or topical flea/tick treatments your dog is receiving before initiating selegiline.
Side Effects
- Vomiting
- Diarrhea
- Restlessness or agitation
- Salivation
- Anorexia
- Lethargy
- Dizziness or ataxia
- Severe hypertensive crisis (if combined with contraindicated drugs)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
